Here is a synopsis of why SPB and CREE have a Zacks Rank of #5 (Strong Sell) and should most likely be sold or avoided for the next one to three months. Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the Zacks Rank universe:
Spectrum Brands Holdings, Inc. (SPG) reported fourth-quarter earnings per share of 25 cents on December 6, which came in 10 cents shy of the Zacks Consensus Estimate. The full-year average forecast dipped 37 cents to $1.76 per share in the last 60 days as covering analysts lowered expectations. Next year?s estimate dropped 59 cents to $2.86 per share in a span of 30 days.
Cree, Inc.?s (CREE) second -quarter earnings of 47 cents per share, announced on January 18, lagged the Zacks Consensus Estimate by 4 cents. The average forecast for 2011 decreased 37 cents to a profit of $1.78 per share in the last 7 days. During that time period, the following year?s estimate moved down 32 cents to $2.12 per share.
Here is a synopsis of why BKS and LONG have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;
Barnes & Noble, Inc. (BKS) posted a second-quarter loss of 22 cents per share on November 30 while analysts projected a loss of 7 cents. The Zacks Consensus Estimate for the current year is pegged at a loss of 78 cents per share, a decline of 39 cents in the last 60 days. The average forecast for 2012 slid down 21 cents to a loss of 23 cents per share.
eLong, Inc. (LONG) announced a third-quarter profit of a penny per share on November 11, which was missed the Zacks Consensus Estimate my 6 cents. The Zacks Consensus Estimate for the full year decreased 12 cents to 13 cents per share over the past 90 days as the covering analysts reduced expectations.
BARNES & NOBLE (BKS): Free Stock Analysis Report
CREE INC (CREE): Free Stock Analysis Report
ELONG INC-ADR (LONG): Free Stock Analysis Report
SPECTRUM BRANDS (SPB): Free Stock Analysis Report
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.